These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15126889)

  • 1. Agreement between self-rated and clinically assessed symptoms in subjects with psychosis.
    Liraud F; Droulout T; Parrot M; Verdoux H
    J Nerv Ment Dis; 2004 May; 192(5):352-6. PubMed ID: 15126889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor structure of symptoms in functional psychoses.
    Peralta V; Cuesta MJ; Farre C
    Biol Psychiatry; 1997 Nov; 42(9):806-15. PubMed ID: 9347129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paranoid delusions in schizophrenia spectrum disorders and depression: the transdiagnostic role of expectations of negative events and negative self-esteem.
    Bentall RP; Rowse G; Kinderman P; Blackwood N; Howard R; Moore R; Cummins S; Corcoran R
    J Nerv Ment Dis; 2008 May; 196(5):375-83. PubMed ID: 18477879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among negative, positive, and depressive symptoms in schizophrenia and psychotic depression.
    Sax KW; Strakowski SM; Keck PE; Upadhyaya VH; West SA; McElroy SL
    Br J Psychiatry; 1996 Jan; 168(1):68-71. PubMed ID: 8770431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.
    Pini S; Cassano GB; Dell'Osso L; Amador XF
    Am J Psychiatry; 2001 Jan; 158(1):122-5. PubMed ID: 11136644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
    Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA
    J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociating self-reported cognitive complaint from clinical insight in schizophrenia.
    Bayard S; Capdevielle D; Boulenger JP; Raffard S
    Eur Psychiatry; 2009 May; 24(4):251-8. PubMed ID: 19324531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new instrument for measuring insight: the Beck Cognitive Insight Scale.
    Beck AT; Baruch E; Balter JM; Steer RA; Warman DM
    Schizophr Res; 2004 Jun; 68(2-3):319-29. PubMed ID: 15099613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative symptoms in the course of first-episode affective psychosis.
    Husted JA; Beiser M; Iacono WG
    Psychiatry Res; 1995 Mar; 56(2):145-54. PubMed ID: 7667439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the relative importance of self reported psychotic symptoms in epidemiological studies? Results from the ESEMeD--Catalonia Study.
    Ochoa S; Haro JM; Torres JV; Pinto-Meza A; Palacín C; Bernal M; Brugha T; Prat B; Usall J; Alonso J; Autonell J
    Schizophr Res; 2008 Jul; 102(1-3):261-9. PubMed ID: 18495432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
    Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rumination and negative symptoms in schizophrenia.
    Halari R; Premkumar P; Farquharson L; Fannon D; Kuipers E; Kumari V
    J Nerv Ment Dis; 2009 Sep; 197(9):703-6. PubMed ID: 19752652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariance of affective and schizophrenic symptoms in schizoaffective psychosis.
    Silva JA; Yesavage JA
    J Nerv Ment Dis; 1980 Sep; 168(9):559-61. PubMed ID: 7411130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Illness-related components for the family burden of relatives to patients with psychotic illness.
    Hjärthag F; Helldin L; Karilampi U; Norlander T
    Soc Psychiatry Psychiatr Epidemiol; 2010 Feb; 45(2):275-83. PubMed ID: 19452109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A ten-year longitudinal study of intense ambivalence as a predictor of risk for psychopathology.
    Kwapil TR; Raulin ML; Midthun JC
    J Nerv Ment Dis; 2000 Jul; 188(7):402-8. PubMed ID: 10919697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life in schizophrenia spectrum disorders: associations with insight and psychopathology.
    Margariti M; Ploumpidis D; Economou M; Christodoulou GN; Papadimitriou GN
    Psychiatry Res; 2015 Feb; 225(3):695-701. PubMed ID: 25544550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of resistance to voices on depression].
    Monestès JL; Vavasseur-Desperriers J; Villatte M; Denizot L; Loas G; Rusinek S
    Encephale; 2015 Feb; 41(1):25-31. PubMed ID: 24815790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.